Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Compared with SARS-CoV2 wild type’s spike protein, the SARS-CoV2 omicron’s receptor binding motif has adopted a more SARS-CoV1 and/or bat/civet-like structure

View ORCID ProfileMichael O. Glocker, Kwabena F.M. Opuni, Hans-Juergen Thiesen
doi: https://doi.org/10.1101/2021.12.14.472585
Michael O. Glocker
1Proteome Center Rostock, University Medicine Rostock and University of Rostock, Schillingallee 69, 18059 Rostock, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael O. Glocker
  • For correspondence: michael.glocker@med.uni-rostock.de
Kwabena F.M. Opuni
2Department of Pharmaceutical Chemistry, School of Pharmacy, College of Health Science, University of Ghana, P. O. Box LG43 Legon, Ghana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Juergen Thiesen
3Institute of Immunology, University Medicine Rostock, Schillingallee 69, 18059, Rostock, Germany
4Gesellschaft für Indivualisierte Medizin mbH (IndyMED), Industriestr.15, 18069 Rostock, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Our study focuses on free energy calculations of SARS-CoV2 spike protein receptor binding motives (RBMs) from wild type and variants-of-concern with particular emphasis on currently emerging SARS- CoV2 omicron variants of concern (VOC). Our computational free energy analysis underlines the occurrence of positive selection processes that specify omicron host adaption and bring changes on the molecular level into context with clinically relevant observations. Our free energy calculations studies regarding the interaction of omicron’s RBM with human ACE2 shows weaker binding to ACE2 than alpha’s, delta’s, or wild type’s RBM. Thus, less virus is predicted to be generated in time per infected cell. Our mutant analyses predict with focus on omicron variants a reduced spike-protein binding to ACE2-receptor protein possibly enhancing viral fitness / transmissibility and resulting in a delayed induction of danger signals as trade-off. Finally, more virus is produced but less per cell accompanied with delayed Covid-19 immunogenicity and pathogenicity. Regarding the latter, more virus is assumed to be required to initiate inflammatory immune responses.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • Footnote page:

  • 1) The authors declare no conflicts of interest. (e.g., pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding)

  • 2) The authors declare that no funding sources have been engaged for writing this manuscript. (including grant numbers)

  • 3) The authors declare that content of this paper has not been published elsewhere. (including scientific meetings)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 15, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Compared with SARS-CoV2 wild type’s spike protein, the SARS-CoV2 omicron’s receptor binding motif has adopted a more SARS-CoV1 and/or bat/civet-like structure
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Compared with SARS-CoV2 wild type’s spike protein, the SARS-CoV2 omicron’s receptor binding motif has adopted a more SARS-CoV1 and/or bat/civet-like structure
Michael O. Glocker, Kwabena F.M. Opuni, Hans-Juergen Thiesen
bioRxiv 2021.12.14.472585; doi: https://doi.org/10.1101/2021.12.14.472585
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Compared with SARS-CoV2 wild type’s spike protein, the SARS-CoV2 omicron’s receptor binding motif has adopted a more SARS-CoV1 and/or bat/civet-like structure
Michael O. Glocker, Kwabena F.M. Opuni, Hans-Juergen Thiesen
bioRxiv 2021.12.14.472585; doi: https://doi.org/10.1101/2021.12.14.472585

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Molecular Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3704)
  • Biochemistry (7829)
  • Bioengineering (5706)
  • Bioinformatics (21364)
  • Biophysics (10613)
  • Cancer Biology (8217)
  • Cell Biology (11985)
  • Clinical Trials (138)
  • Developmental Biology (6792)
  • Ecology (10431)
  • Epidemiology (2065)
  • Evolutionary Biology (13918)
  • Genetics (9734)
  • Genomics (13118)
  • Immunology (8182)
  • Microbiology (20082)
  • Molecular Biology (7882)
  • Neuroscience (43204)
  • Paleontology (321)
  • Pathology (1285)
  • Pharmacology and Toxicology (2270)
  • Physiology (3367)
  • Plant Biology (7263)
  • Scientific Communication and Education (1317)
  • Synthetic Biology (2012)
  • Systems Biology (5552)
  • Zoology (1135)